“A drug called Xeloda can extend the lives of some women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds.
“Oncologists said the results are ‘practice-changing.’
” ‘This drug is already approved, and we’ve been using it for a long time in cancer treatment,’ said Dr. Stephen Malamud, an oncologist at Mount Sinai in New York City.
“Xeloda (capecitabine) is a pill, so it’s easy to take and is ‘much less toxic’ than standard chemotherapy, noted Malamud, who was not involved in the new research.”
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to use our ASK Cancer Commons service.